• OPEN AN ACCOUNT
Indian Indices
Sensex
78,154.25 -388.19
( -0.49%)
Global Indices
Nasdaq
53,996.18 -61.75
(-0.11%)
Dow Jones
7,774.29 -4.35
(-0.06%)
Hang Seng
66,870.65 1,263.94
(1.93%)
Nikkei 225
10,869.98 -31.11
(-0.29%)
Forex
USD-INR
95.15 -0.05
(-0.05%)
EUR-INR
109.97 0.14
(0.13%)
GBP-INR
128.34 0.21
(0.16%)
JPY-INR
0.60 0.00
(0.09%)

EQUITY - MARKET SCREENER

Advanced Enzyme Technologies Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
540025
INE837H01020
63.3529756
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ADVENZYMES
39.78
3296.02
EPS(TTM)
Face Value()
Div & Yield %
7.4
2
1.82
 

20 Microns consolidated net profit rises 15.77% in the March 2026 quarter
May 22,2026
Net profit of 20 Microns rose 15.77% to Rs 17.62 crore in the quarter ended March 2026 as against Rs 15.22 crore during the previous quarter ended March 2025. Sales rose 14.80% to Rs 261.06 crore in the quarter ended March 2026 as against Rs 227.41 crore during the previous quarter ended March 2025.

For the full year,net profit rose 7.13% to Rs 66.83 crore in the year ended March 2026 as against Rs 62.38 crore during the previous year ended March 2025. Sales rose 4.50% to Rs 953.83 crore in the year ended March 2026 as against Rs 912.79 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales261.06227.41 15 953.83912.79 5
OPM %12.1012.68 -12.8512.86 -
PBDT29.7624.29 23 111.63103.00 8
PBT24.5819.33 27 91.1184.74 8
NP17.6215.22 16 66.8362.38 7